Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.1000
0.00 (0.00%)
Jun 4, 2025, 11:37 AM EDT
-41.18%
Market Cap 1.39M
Revenue (ttm) n/a
Net Income (ttm) -317.92K
Shares Out 13.86M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,700
Average Volume 10,790
Open 0.1000
Previous Close 0.1000
Day's Range 0.1000 - 0.1000
52-Week Range 0.0750 - 0.4500
Beta 1.60
RSI 39.39
Earnings Date Jun 30, 2025

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.